- active not recruitingPHASE3
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
This study compares two chemotherapy treatments for germ cell tumours that have returned or didn't respond to previous treatment. It looks at a standard chemotherapy plan versus a stronger plan with a stem cell transplant to see which works better.
United States · Australia · Belgium - recruitingPHASE2
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
This study for men with a specific type of testicular cancer (seminoma) looks at a new surgery using robotic help. It aims to reduce side effects from usual treatments like chemotherapy and improve quality of life, focusing on better ways to predict who benefits most.
Germany - active not recruiting
A Study of miRNA 371 in Patients With Germ Cell Tumors
This study looks at a special marker called miRNA 371 in blood tests for people with germ cell tumours. The aim is to see if this marker can help predict if the cancer might return, allowing doctors to better understand and manage the risk.
United States · Canada · Guam - recruitingPHASE2
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
This study looks at how a special scan called a PET-TDM can help doctors decide on the best treatment for men with seminoma, a type of testicular cancer. They want to see if this scan can lead to a gentler treatment plan for some patients.
France - recruiting
THERApy De-escalation for TESTicular Cancer
This study, called THERATEST, is looking at different ways to treat a type of testicular cancer called seminoma. It aims to see if patients are open to trying new, possibly gentler treatments and how these treatments affect their health and quality of life, preparing for bigger studies in the future.
United Kingdom